EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Journal Title
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

EUR J PHARM BIOPHARM

ISSN / eISSN
0939-6411 / 1873-3441
Aims and Scope
The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics.

Topics covered include for example:

Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids)
Aspects of manufacturing process design
Biomedical aspects of drug product design
Strategies and formulations for controlled drug transport across biological barriers
Physicochemical aspects of drug product development
Novel excipients for drug product design
Drug delivery and controlled release systems for systemic and local applications
Nanomaterials for therapeutic and diagnostic purposes
Advanced therapy medicinal products
Medical devices supporting a distinct pharmacological effect.
Subject Area

PHARMACOLOGY & PHARMACY

CiteScore
9.80 View Trend
CiteScore Ranking
Category Quartile Rank
Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science Q1 #20/171
Pharmacology, Toxicology and Pharmaceutics - Biotechnology Q1 #46/299
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
PHARMACOLOGY & PHARMACY - SCIE Q1
H-index
138
Country/Area of Publication
NETHERLANDS
Publisher
Elsevier
Publication Frequency
Bimonthly
Year Publication Started
1991
Annual Article Volume
225
Open Access
NO
Contact
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started